Published on
Last updated on
NMPA Draft Catalog of Class III Medical Devices Requiring Clinical Trials
On June 24, the NMPA released the draft catalog of class III medical devices requiring clinical trial approval. In the draft catalog, the following device categories were proposed:
- Implantable cardiac rhythm management device
- Implantable ventricular assist system
- Implantable drug infusion device
- Artificial heart valve and intravascular stent
- Tissue engineering medical products containing living cells
- Absorbable implants for the fixation of long bone
The public consultation is currently running until July 31, 2020.
By Jacky Li. Contact Cisema if you would like to learn more about the above news.
Related News
Malaysia Introduces New e-IFU & Digital Labelling Guidance for Medical Devices
Malaysia’s MDA publishes the 7th edition of guidance on medical device labelling, with new e-labelling, e-IFU, and accessibility requirements
Vietnam Authorities Step Up Cosmetic Recalls as Enforcement Tightens
Vietnam’s Drug Administration (DAV) is stepping up cosmetic product recalls as post-market surveillance tightens.
BPOM Clarifies Indonesia–US Trade Agreement Impact on Pharmaceutical Regulation
BPOM confirms pharmaceutical authorization, GMP oversight, and regulatory authority remain unchanged under the Indonesia–US trade agreement.